✦ LIBER ✦
1123-183 Sustained hemodynamic benefit in patients with pulmonary arterial hypertension after one-year of therapy with the selective orally-active endothelin-A receptor antagonist, sitaxsentan
✍ Scribed by David Langleben; Andrew Hirsch; Eileen Shalit; Lyda Lesenko; Robyn J Barst; Mortimer B Davis
- Book ID
- 119549736
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 265 KB
- Volume
- 43
- Category
- Article
- ISSN
- 1558-3597
No coin nor oath required. For personal study only.